Aktis Oncology, Inc. AKTS

Set alert

14.94 USD +0.35 (+2.40%)

At closeNov 3, 2026, 6:08 PM EST

15.05 +0.11 +0.74%

After hours · Nov 3, 6:08 PM ET

14.40 Day range 15.09

13.96 52-week range 34.19

Held by insiders 14.05%

Held by institutions 73.01%

Float held by institutions 84.94%

Institutions 164

Top institutional holders
Holder	% held	Shares	Value	Reported
MPM Bioimpact LLC	9.00%	4,835,872	87.77M	Jun 29, 2026
EcoR1 Capital, LLC	8.98%	4,824,469	87.56M	Jun 29, 2026
Blue Owl Capital Holdings LP	5.71%	3,070,219	55.72M	Jun 29, 2026
Blackrock Inc.	4.24%	2,278,358	41.35M	Jun 29, 2026
T. Rowe Price Investment Management, Inc.	3.82%	2,051,447	37.23M	Jun 29, 2026
Wellington Management Group, LLP	3.66%	1,966,244	35.69M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund	2.72%	1,462,244	26.54M	Jul 30, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.	1.26%	676,577	12.28M	Jun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	1.09%	585,135	10.62M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	1.01%	542,593	9.85M	Aug 30, 2026
MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund	0.94%	507,000	9.20M	Jun 29, 2026
T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd.	0.67%	358,947	6.51M	Jun 29, 2026

AKTS insiders
Insider	Relation	Latest transaction	Date
CZIBERE AKOS M.D.	Officer	Sale	Sep 22, 2026
ECOR1 CAPITAL, L.L.C.	Unknown	Purchase	Jan 11, 2026
FOLEY TODD	Director and Beneficial Owner of more than 10% of a Class of Security	Purchase	Jan 11, 2026
GADICKE ANSBERT S.	Beneficial Owner of more than 10% of a Class of Security	Purchase	Jan 11, 2026
HERRMANN KEN M.D.	Director	Sale	Jul 19, 2026
KIM HELEN SUSAN	Director and Beneficial Owner of more than 10% of a Class of Security	Purchase	Jan 11, 2026

Held by funds